标题
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
作者
关键词
-
出版物
Gastroenterology Report
Volume 8, Issue 1, Pages 25-30
出版商
Oxford University Press (OUP)
发表日期
2019-12-11
DOI
10.1093/gastro/goz065
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immune checkpoint inhibitor-induced colitis: A comprehensive review
- (2019) Aniruddh Som et al. World Journal of Clinical Cases
- Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury
- (2019) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases
- (2019) Suheil Albert Atallah-Yunes et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immune-related pancreatitis associated with checkpoint blockade in melanoma
- (2019) Johannes Kohlmann et al. MELANOMA RESEARCH
- Immune‐related Adverse Events in Cancer Patients
- (2018) Daniel J. Pallin et al. ACADEMIC EMERGENCY MEDICINE
- Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
- (2018) Angeliki M. Stamatouli et al. DIABETES
- Isolated immune-related pancreatic exocrine insufficiency associated with pembrolizumab therapy
- (2018) Thiru Prasanna et al. Immunotherapy
- Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis
- (2018) Yinghong Wang et al. INFLAMMATORY BOWEL DISEASES
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
- (2018) Eleonora De Martin et al. JOURNAL OF HEPATOLOGY
- Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury
- (2018) Yoh Zen et al. MODERN PATHOLOGY
- Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?
- (2018) Kati Choi et al. INFLAMMATORY BOWEL DISEASES
- Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians
- (2018) Adam T. Hryniewicki et al. JOURNAL OF EMERGENCY MEDICINE
- Immune Checkpoint Inhibitor-Associated Colits and Hepatitis
- (2018) Haritha G. Reddy et al. Clinical and Translational Gastroenterology
- Diabetic ketoacidosis induced by a single dose of pembrolizumab
- (2018) Julian Maamari et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?
- (2018) Mar Riveiro-Barciela et al. JOURNAL OF HEPATOLOGY
- Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
- (2018) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
- (2018) Daniel H Johnson et al. Journal for ImmunoTherapy of Cancer
- Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
- (2017) Vivek Kumar et al. Frontiers in Pharmacology
- Potential immune biomarkers of gastrointestinal toxicities and efficacy in patients with advanced melanoma treated with ipilimumab with or without prophylactic budesonide
- (2017) D. Berman et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibody-Mediated Thyroid Dysfunction During T-cell Checkpoint Blockade in Patients with Non-Small Cell Lung Cancer
- (2016) J.C. Osorio et al. ANNALS OF ONCOLOGY
- Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
- (2016) Lars Hofmann et al. EUROPEAN JOURNAL OF CANCER
- Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease
- (2016) L. Marthey et al. Journal of Crohns & Colitis
- Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report
- (2016) Kazuhiko Ikeuchi et al. LUNG CANCER
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
- (2015) Troy Z. Horvat et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunopathogenesis of IBD: current state of the art
- (2015) Heitor S. P. de Souza et al. Nature Reviews Gastroenterology & Hepatology
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
- (2015) Ahmad A. Tarhini et al. Journal for ImmunoTherapy of Cancer
- Gastroenteric tube feeding: Techniques, problems and solutions
- (2014) Irina Blumenstein WORLD JOURNAL OF GASTROENTEROLOGY
- Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases
- (2013) Marwan Ghabril et al. Clinical Gastroenterology and Hepatology
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started